Use of psychoactive drugs by the elderly

Prescribing patterns for elderly community-dwelling heavy medicinal drug users in Manitoba, Canada and Jämtland, Sweden.

Journal of clinical epidemiology·1995

Prescribing patterns for older heavy drug users living in the community.

DICP : the annals of pharmacotherapy·1991

Long-term captopril in young and old patients with mild hypertension.

Journal of clinical pharmacology·1991

Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: influence of dose formulation and institutionalization.

Biopharmaceutics & drug disposition·1989

Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertension.

Clinical pharmacology and therapeutics·1989

Drug-associated hospital admissions in older medical patients.

Journal of the American Geriatrics Society·1988

Delirium in Hospitalized Trauma Surgery Patients Cared by Geriatric Trauma Co-Management and Standard Care: A Propensity Score-Matched Analysis.

Gerontology·2026

Wearable-Derived Digital Biomarkers for Mobility Assessment and Risk Stratification in Older Adults: A Scoping Review.

Gerontology·2026

Time- vs. Step-Based Physical Activity Metrics for Disability Incidence in Older Adults.

Gerontology·2026

Machine learning classification of frailty using wearable-derived sleep metrics in community-dwelling older adults.

Gerontology·2026

Post COVID-19 condition diagnosis among older people: findings from Swedish national register data.

Gerontology·2026

A Body Shape Index (ABSI) Shows Stronger Associations with Falls than BMI Among Older Adults: Evidence from the NHATS Cohort.

Gerontology·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

Use of psychoactive drugs by the elderly

Related Concept Videos

Prescribing patterns for elderly community-dwelling heavy medicinal drug users in Manitoba, Canada and Jämtland, Sweden.

Prescribing patterns for older heavy drug users living in the community.

Long-term captopril in young and old patients with mild hypertension.

Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: influence of dose formulation and institutionalization.

Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertension.

Drug-associated hospital admissions in older medical patients.

Delirium in Hospitalized Trauma Surgery Patients Cared by Geriatric Trauma Co-Management and Standard Care: A Propensity Score-Matched Analysis.

Wearable-Derived Digital Biomarkers for Mobility Assessment and Risk Stratification in Older Adults: A Scoping Review.

Time- vs. Step-Based Physical Activity Metrics for Disability Incidence in Older Adults.

Machine learning classification of frailty using wearable-derived sleep metrics in community-dwelling older adults.

Post COVID-19 condition diagnosis among older people: findings from Swedish national register data.

A Body Shape Index (ABSI) Shows Stronger Associations with Falls than BMI Among Older Adults: Evidence from the NHATS Cohort.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

Use of psychoactive drugs by the elderly

Related Concept Videos

Related Articles